Correction to: Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial (vol 20, 431, 2019)

"Background: Either benznidazole (BZN) or nifurtimox (NFX) is recommended as equivalent to treat Trypanosoma cruzi infection. Nonetheless, supportive data from randomised trials is limited to individuals treated with BZN in southern cone countries of Latin America. Methods: The goal of this ran...

Descripción completa

Detalles Bibliográficos
Autores Principales: Carlos Villar, Juan, Herrera, Victor Mauricio, Perez Carreno, Juan Guillermo, Vaquiro Herrera, Eliana, Castellanos Dominguez, Yeny Zulay, Marcell Vasquez, Skarlet, Milena Cucunuba, Zulma, Graciela Prado, Nilda, Hernandez, Yolanda
Formato: Artículo (Article)
Lenguaje:Inglés (English)
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://repository.urosario.edu.co/handle/10336/26006
https://doi.org/10.1186/s13063-019-3630-y